Skip to main content
    C

    Cohen & Steers Inc (CNS)

    Official site

    FINANCIAL SERVICES • ASSET MANAGEMENT • NYSE

    $68.36
    -1.61 (-2.30%)

    Market Cap: $3.60B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Cohen & Steers Inc (CNS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cohen & Steers (CNS) has a market cap of $3.60B and an enterprise value of $3.54B. Its return on invested capital of 24.81% compares with a 5.26% median across 8 similar companies.

    Total Valuation

    Enterprise value is 1.66% below the market cap, as cash exceeds debt.

    Market Cap$3.60B
    Enterprise Value$3.54B
    Latest price (Nov 17, 2026)$68.36

    Key Dates

    The next earnings report is expected on Jan 20, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 9, 2026.

    Next Earnings DateJan 20, 2027 (expected)
    Last Earnings DateOct 15, 2026
    Last Ex-Dividend DateNov 9, 2026
    Next Payment DateNov 19, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.04% in the quarter ended Sep 30, 2026 and grew 0.77% a year over 2 years.

    Shares Outstanding51.57M
    Shares Change (YoY)+0.71%
    Shares Change (QoQ)+0.04%
    Share Count Growth (2Y CAGR)+0.77%

    Valuation Ratios

    Sales and book value multiples are 5.8x and 5.8x. Its year-end P/E ranged from 14.2x to 31.5x from 2016 to 2025.

    P/E Ratio20.5x
    Forward P/E19.6x
    P/S Ratio5.8x
    Forward P/S5.9x
    P/B Ratio5.8x
    P/TBV Ratio6.0x
    P/FCF Ratio99.2x
    P/OCF Ratio94.8x
    PEG Ratio2.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 15.8x EBITDA and 97.5x free cash flow.

    EV / Earnings21.0x
    EV / Sales5.8x
    EV / EBITDA15.8x
    EV / FCF97.5x

    Price Statistics

    The stock is up 7.65% over 52 weeks and trades 4.74% below its 50-day average.

    Beta (1Y)0.61
    52-Week Change+7.65%
    1-Month Change+0.83%
    3-Month Change-15.03%
    6-Month Change-3.89%
    5-Year Change-23.62%
    10-Year Change+94.94%
    Total Return (1Y)+11.87%
    Total Return (3Y CAGR)+8.36%
    Total Return (5Y CAGR)-4.49%
    Return vs SPY (1Y)+6.12%
    Max Drawdown (1Y)-22.49%
    Max Drawdown (3Y)-42.60%
    Sharpe Ratio (1Y)0.61
    Correlation with SPY (1Y)0.32
    50-Day Average$71.76
    200-Day Average$71.48
    52-Week Range$56.28 to $85.77
    RSI (14 Days)39.9
    Average Volume (20 Days)248.21K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Total debt is 0.01x shareholder equity.

    Debt / Equity0.01x
    Debt / EBITDA0.03x
    Debt / FCF0.18x

    Returns and Efficiency

    Return on invested capital is 24.81% over the last 12 months, against a 5-year average of 28.97%.

    Return on Equity (ROE)27.70%
    Return on Assets (ROA)17.18%
    Return on Invested Capital (ROIC)24.81%
    ROE (5Y Average)45.71%
    ROA (5Y Average)24.93%
    ROIC (5Y Average)28.97%
    Asset Turnover0.69x

    Taxes

    Income tax took 26.01% of pretax income over the last 12 months.

    Income Tax (TTM)$59.18M
    Effective Tax Rate26.01%

    Scores

    CNS has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $611.23M over the last 12 months is up 8.82% from the 12 months before.

    Revenue$611.23M
    Revenue Growth (YoY)+8.82%
    Pretax Income$227.50M
    Net Income$168.32M
    Reported EPS (TTM)$3.34

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 62.02% of the $979.82M in total assets.

    Cash and Equivalents$66.12M
    Total Debt$6.39M
    Net Cash$59.73M
    Net Cash Per Share$1.16
    Shareholder Equity$607.68M
    Book Value Per Share$11.78
    Tangible Book Value$588.00M
    Tangible Book Per Share$11.40
    Total Assets$979.82M
    Total Liabilities$231.09M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.40M of capital spending, operating cash flow left $35.55M of free cash flow.

    Operating Cash Flow$37.94M
    Capital Expenditures$2.40M
    Free Cash Flow$35.55M
    FCF Per Share$0.69
    Depreciation and Amortization$13.01M
    Dividends Paid$135.35M
    Share Repurchases$19.23M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    Pretax Margin37.22%
    Net Margin27.54%
    FCF Margin5.82%
    Gross Margin (5Y Average)50.94%
    Operating Margin (5Y Average)36.04%
    Net Margin (5Y Average)30.23%

    Growth

    Revenue grew 1.40% a year over 3 years, and EPS fell 5.81% a year.

    Revenue Growth (3Y CAGR)+1.40%
    Revenue Growth (5Y CAGR)+5.93%
    EPS Growth (3Y CAGR)-5.81%
    EPS Growth (5Y CAGR)+3.74%
    Operating Income Growth (3Y CAGR)-6.28%
    Book Value Per Share Growth (2Y CAGR)+19.14%
    Tangible Book Per Share Growth (2Y CAGR)+20.09%

    Revenue and profit by year

    Dividends and Yields

    CNS pays out 82.10% of earnings as dividends.

    Dividend Per Share (Annual)$2.68
    Dividend Yield3.92%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+4.07%
    Dividend Growth (5Y CAGR)+16.21%
    Payout Ratio82.10%
    FCF Payout Ratio380.78%
    Earnings Yield4.88%
    FCF Yield1.01%
    Buyback Yield0.51%
    Shareholder Yield4.35%

    Full dividend history

    Peer Position

    Against 11 similar companies, CNS has the 2nd highest P/E and the 7th highest P/S.

    P/E Ratio20.5x vs 9.2x median
    P/S Ratio5.8x vs 6.0x median
    ROIC24.81% vs 5.26% median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.82% vs +3.65% median
    Dividend Yield3.92% vs 7.10% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.83% and EPS growth at 9.35% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.83%
    EPS Growth Forecast (2Y CAGR)+9.35%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CNS

    What is CNS's market cap?

    Cohen & Steers has a market cap of $3.60B. Its enterprise value, which adds debt and subtracts cash, is $3.54B.

    What is CNS's P/E ratio?

    Cohen & Steers has a trailing P/E ratio of 20.5x and a forward P/E of 19.6x.

    How many shares of CNS are outstanding?

    Cohen & Steers has 51.57M shares outstanding. The count is up 0.71% from a year earlier.

    Does CNS pay a dividend?

    Yes. Cohen & Steers pays $2.68 a share a year, a dividend yield of 3.92%.

    How much debt does CNS have?

    Cohen & Steers has $6.39M of total debt and $66.12M of cash and equivalents, a net cash position of $59.73M.